Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level

Behavioural Brain Research

Volumn 170, Issue 2, 2006, Pages 293-301

  Fu, Cai Yun ^a   Yang, Qi ^a   Wang, Kai Rong ^a   Kong, Zi Qing ^a   Chen, Qiang ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Antinociception; Endogenous opioids; Morphine; Naloxone; Peripheral and supraspinal level; Tachykinin

Indexed keywords

HEMOKININ 1; MORPHINE; NALOXONE; TACHYKININ; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFECT; DRUG POTENTIATION; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG SYNERGISM; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PAIN MEASUREMENT; PROTEIN PRECURSORS; REACTION TIME; TACHYKININS; TIME FACTORS;

EID: 33646520610     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.03.007     Document Type: Article

References (47)

1. Aicher S.A., Punnoose A., and Goldberg A. My opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn. J Neurosci 20 (2000) 4345-4354
2. Barbaresi P. Immunocytochemical localization of substance P receptor in rat periaqueductal rey matter: a light and electron microscopic study. J Comp Neurol 398 (1998) 473-490
3. Bellucci F., Carini F., Catalani C., Cucchi P., Lecci A., Meini S., et al. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol 135 (2002) 266-274
4. Bester H., De Felipe C., and Hunt S.P. The NK-1 receptor is essential for the full expression of noxious inhibitory controls in the mouse. J Neurosci 21 (2000) 1039-1046
5. Camarda V., Rizzi A., Calo G., Guerrini R.S., and Regoli D. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci 71 (2002) 363-370
6. Del Rio J., Naranjo J.R., and Yang H.Y.T. Substance P induced release of met-enkephalin from striatal and periaqueductal gray slices. Brain Res 279 (1983) 121-126
7. Duffy R.A., Hedrick J.A., Randolph G., Morgan C.A., Cohen-Williams M.E., Vassileva G., et al. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. Neuropharmacology 45 (2003) 242-250
8. Frederickson R.C., Burgis V., Harrell C.E., and Edwards J.D. Dual actions of substance P on nociception: possible role of endogenous opioids. Science 199 (1978) 1359-1362
9. Fu C.Y., Kong Z.Q., Wang K.R., Yang Q., Zhai K., Chen Q., et al. Effects and mechanisms of supraspinal administration of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on nociception in mice. Brain Res 1056 (2005) 51-58
10. Gerard N.P., Eddy Jr. R.L., Shows T.B., and Gerard C. The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues. J Biol Chem 265 (1990) 20455-20462
11. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 12 (1957) 12-15
12. Han J.S., Xie G.X., and Zhou Z.F. Acupuncture mechanisms in rabbits studied with microinjection of antibodies against beta-endorphin, enkephalin and substance P. Neuropharmacology 1 (1984) 1-5
13. Harrison S., and Geppetti P. Substance P, review. Int J Biochem Cell Biol 33 (2001) 555-576
14. Hirota N., Kuraishi Y., Hino Y., Sato Y., Satoh M., and Takagi H. Met-enkephalin and morphine but not dynorphin inhibit noxious-stimuli-induced release of substance P from rabbit dorsal horn in situ. Neuropharmacology 24 (1985) 567-570
15. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropetides. Neuroscience 24 (1988) 739-768
16. Iadarola M.J., Tang J., Costa E., and Yang H.Y. Analgesic activity and release of [Met5]Enkephalin-Arg6-Gly7-Leu8 from rat spinal cord in vivo. Eur J Pharmacol 121 (1986) 39-48
17. Improta G., and Broccardo M. Effects of supraspinal administration of PG-SPI and PG-KII, two amphibian tachykinin peptides, on nociception in the rat. Peptides 21 (2000) 1611-1616
18. Ingi T., Kitajima Y., Minamitake Y., and Nakanishi S. Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells. J Pharmacol Exp Ther 259 (1991) 968-975
19. Jessel T.M., and Iversen L.L. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature 268 (1977) 549-551
20. Johnston I.N., and Westbrook R.F. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia. Behav Brain Res 156 (2005) 75-83
21. Kellstein D.E., Price D.D., Hayes R.L., and Mayer D.J. Evidence that substance P selectively modulates C-fiber-evoked of dorsal horn nociceptive neurons. Brain Res 526 (1990) 291-298
22. Kream R.M., Kato T., Shimonaka H., Marchand J.E., and Wurm W.H. Substance P markedly potentiates the antinociceptive effects of morphine sulfate administered at the spinal level. Proc Natl Acad Sci USA 90 (1993) 3564-3568
23. Kurtz M.M., Wang R., Clements M.K., Cascieri M.A., Austin C.P., Cunningham B.R., et al. Identification, localization and receptor characterization of novel mammalian substance-like peptides. Gene 296 (2002) 205-212
24. Lembeck F., and Connerer J. Opioid control of the function of primary afferent substance P fibres. Eur J Pharmacol 114 (1985) 241-246
25. Ma Q.P., and Hill R.G. Neurokinin antagonists as potential agents for use in pain management. Curr Opin Invest Drugs 1 (1999) 65-71
26. Mantyh P.W., DeMaster E., and Malhotra A. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 268 (1995) 1629-1632
27. Mantyh P.W., and Hunt S.P. The autoradiographic localization of substance P receptors in the rat and bovine spinal cord and the rat and cat spinal trigeminal nucleus pars caudalis and the effects of neonatal capsaicin. Brain Res 332 (1985) 315-324
28. Morteau O., Lu B., Gerard C., and Gerard N.P. Hemokinin 1 is a full agonist at the substance P receptor. Nat Immunol 2 (2001) 1088
29. Naranjo J.R., Arnedo A., De Felipe M.C., and Del Rio J. Antinociceptive and Met-Enkephalin releasing effects of tachykinins and substance P fragments. Peptides 7 (1986) 419-423
30. 1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites. Life Sci 70 (2002) 2341-2354
31. Nelson D.A., and Bost K.L. Non-neuronal mammalian tachykinin expression. Front Biosci 9 (2004) 2166-2176
32. Radhakrishnan V., and Henry J.L. Electrophysiology of neuropeptides in the sensory spinal cord. Prog Brain Res 104 (1995) 175-195
33. Regoli D., Boudon A., and Fauche're J.L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 46 (1994) 551-599
34. Rose'n A., and Brodin E. Effects of acute morphine treatment on peptide levels in the periaqueductal grey. Acta Physiol Scand 136 (1989) 493-494
35. Rose'n A., Zhang Y.X., Lund I., Lundeberg T., and Yu L.C. Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration. Brain Res 1001 (2004) 87-94
36. Sakurada T., Katsumata K., Manome Y., Tan-No K., Sakurado S., Kisara K., et al. Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice. Eur J Pharmacol 242 1 (1993) 47-52
37. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The tachykinin peptide family. Pharmacol Rev 54 (2002) 285-322
38. Skirboll L., Hokfelt T., Dockray G., Rehfeld J., Brownstein M., and Cuello C.J. Evidence for periaqueductal cholecystokinin-substance P neurons projecting to the spinal cord. Neuroscience 3 (1983) 1151-1157
39. Skirboll L., Hokfelt T., Rehfeld J., Cuello A.C., and Dockray G. Coexistence of substance P- and cholecystokinin-like immunoreactivity in neurons of the mesencephalic periaqueductal central gray. Neurosci Lett 28 (1982) 35-39
40. Stewart J.M., Getto C.J., Neldner K., Reeve E.B., Krivoy W.A., and Zimmermann E. Substance P and analgesia. Nature 262 (1976) 784-785
41. Takahashi K., Tanaka A., Hara M., and Nakanishi S. The primary structure and gene organization of human substance P and neuromedin K receptors. Eur J Biochem 204 (1992) 1025-1033
42. Takeda Y., Chou K.B., Takeda J., Sachais B.S., and Krause J.E. Molecular cloning, structural organization and functional expression of the human substance P receptor. Biochem Biophys Res Commun 179 (1991) 1232-1240
43. Tang J., Chou J., Yang H.Y., and Costa E. Substance P stimulates the release of Met5-enkephalin-Arg6-Phe7 and Met5-enkephalin from rat spinal cord. Neuropharmacology 22 (1983) 1147-1150
44. Yaksh T.L., Jessell T.M., Gamse R., Mudge A.W., and Leeman S.E. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 286 (1980) 155-156
45. Xin L., Geller E.B., Liu-Chew L.Y., Chew C., and Adler M.W. Substance P release in the rat periaqueductal grey and preoptic anterior hypothalamus after noxious cold stimulation; effect of selective my and kappa opioid agonists. J Pharmacol Exp Ther 282 (1997) 1055-1063
46. Zhang Y., Lu L., Furlonger C., Wu G.E., and Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol 1 (2000) 392-397
47. Zhou Q., Liu Z.R., Ray A., Huang W., Karlsson K., and Nyberg F. Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats. Neuropharmacology 37 (1998) 1545-1552